Scienture Holdings (SCNX) EBITDA Margin (2013 - 2026)
Scienture Holdings' EBITDA Margin was -519.24% in Q2 2026, up 4099.15 percentage points from the prior quarter.
Powered by 
Analysis
Scienture Holdings (SCNX) EBITDA Margin (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Scienture Holdings' EBITDA Margin was -3196.77% through Jun 30, 2026; for FY2025, it was -9543.68%, up 1213.56 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -9529.07 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -10757.24% in FY2024 (-10496.04 pp), -261.20% in FY2023 (-222.68 pp), -38.52% in FY2022 (+14.92 pp) and -53.44% in FY2021 (-38.83 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q3 2023.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2026 (a gain of 30191.68 percentage points); the worst was Q2 2024 (a drop of 7833.23 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Scienture Holdings | 4.65 Mn | -12.27 Mn | 335,779.00 | -519.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -519.24% |
| Mar 31, 2026 | -4,618.39% |
| Mar 31, 2025 | -29,846.94% |
| Jun 30, 2024 | -7,996.10% |
| Sep 30, 2023 | -40.93% |
| Jun 30, 2023 | -162.87% |
| Mar 31, 2023 | -162.83% |
| Dec 31, 2022 | -74.33% |
| Sep 30, 2022 | -9.79% |
| Jun 30, 2022 | -33.49% |
| Mar 31, 2022 | -29.77% |
| Dec 31, 2021 | -32.67% |
| Sep 30, 2021 | -50.76% |
| Jun 30, 2021 | -135.27% |
| Mar 31, 2021 | -21.04% |
| Dec 31, 2020 | -115.51% |
| Sep 30, 2020 | 2.32% |
| Jun 30, 2020 | -8.10% |
| Mar 31, 2020 | 9.67% |
| Dec 31, 2019 | -20.98% |
API Access
Scienture Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SCNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SCNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SCNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();